GlassScriptPhysician profile
Thomas C Weiner
NPI 1538260179
$13,867.06
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,969 · 2020: $399 · 2021: $7,935 · 2022: $3,564.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,144.70 | 2019-2022 | |
| Emd Serono, INC. | $2,570.00 | 2021 | |
| Kite Pharma, INC. | $1,700.00 | 2021 | |
| Karyopharm Therapeutics INC. | $1,300.00 | 2021 | |
| Daiichi Sankyo INC. | $1,119.60 | 2019-2022 | |
| Beigene, LTD. | $525.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $355.10 | 2019-2020 | |
| Genentech USA, INC. | $213.66 | 2019-2020 | |
| Novocure Gmbh | $200.00 | 2022 | |
| Pfizer INC. | $192.63 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $182.42 | 2019-2020 | |
| Eisai INC. | $169.66 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $167.47 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $165.49 | 2019-2020 | |
| Amgen INC. | $142.91 | 2019-2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $115.01 | 2019-2020 | |
| Celgene Corporation | $93.87 | 2019-2020 | |
| Janssen Biotech, INC. | $48.80 | 2019 | |
| Eusa Pharma (US) LLC | $41.90 | 2020-2021 | |
| Lilly USA, LLC | $41.73 | 2019-2020 | |
| Puma Biotechnology, INC. | $41.41 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.29 | 2019 | |
| Agios Pharmaceuticals, INC. | $35.29 | 2019 | |
| Astellas Pharma US INC | $33.49 | 2019 | |
| Genzyme Corporation | $28.98 | 2019 | |
| Clovis Oncology, INC. | $22.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.08 | 2019 | |
| Stemline Therapeutics INC. | $16.75 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.16 | 2019 | |
| Abbvie INC. | $14.69 | 2019 | |
| Incyte Corporation | $14.50 | 2020 | |
| Taiho Oncology, INC. | $14.06 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $13.55 | 2019 | |
| Exelixis INC. | $13.41 | 2019 | |
| Jazz Pharmaceuticals INC. | $13.27 | 2020 | |
| Medtronic USA, INC. | $12.96 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2019 | |
| Array Biopharma INC | $10.98 | 2019 | |
| Foundation Medicine, INC. | $10.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Weiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.